HS Code for Antimalarial drugs

Antimalarial drugs are classified under HS code 300460 because this specific subheading is dedicated to "Medicaments; containing antimalarial active principles described in Subheading Note 2 to this Chapter, for therapeutic or prophylactic uses, packaged for retail sale." This classification precisely captures pharmaceutical preparations designed to treat or prevent malaria, provided they contain the specified active ingredients and are prepared for direct consumer use. The emphasis on "active principles described in Subheading Note 2" ensures that only specific, recognized antimalarial compounds fall under this category, distinguishing them from general pharmaceutical products.

Products Included

• Chloroquine phosphate tablets
• Artemisinin-based combination therapies (ACTs) suchs as Artemether-Lumefantrine
• Mefloquine hydrochloride tablets
• Doxycycline capsules for malaria prophylaxis
• Primaquine phosphate tablets

Common Misclassification

A common misclassification risk involves HS code 300490, which covers "Other medicaments." Antimalarial drugs should not be classified under 300490 if they contain active principles specifically listed in Subheading Note 2 to Chapter 30, as 300460 is a more specific and appropriate classification. Another potential confusion arises with HS code 3003, which pertains to medicaments not put up in measured doses or for retail sale. If antimalarial active principles are imported in bulk form or not prepared for retail, they would fall under 3003, but once packaged for retail, they transition to 300460.

FAQ

What is the HS code for Antimalarial drugs?

The HS code for antimalarial drugs, when packaged for retail sale and containing specific antimalarial active principles, is 300460.

What criteria define 'antimalarial active principles' under HS 300460?

The criteria for "antimalarial active principles" under HS 300460 are defined by Subheading Note 2 to Chapter 30. This note specifies a list of compounds and their derivatives, such as artemisinin, chloroquine, halofantrine, mefloquine, and primaquine, which are recognized for their antimalarial properties. Products containing these substances, when prepared as medicaments for retail, are classified under this code.